Agilent Altura SEC HPLC Columns With Ultra Inert Technology

Size exclusion chromatography methods can be complicated by unwanted interactions between analytes and the stationary phase. Agilent Altura SEC combines the stationary phase used in the AdvanceBio SEC portfolio with Ultra Inert technology to minimize these secondary interactions. By reducing the need to compensate for column-related effects, it gives scientists greater freedom to optimize method conditions around the characteristics of their samples. This flexibility can support more robust platform methods while simplifying development across a range of analytes.

Explore how effectively designing out secondary interactions can help improve SEC method development and keep the focus on sample-relevant conditions.